Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - TOTAL RECEIVABLES
Total Receivables ITCI - Intra-Cellular Therapies, Inc.
114 M
LAST VALUE
137.84%
2 YEAR CAGR
0.00%
5 YEAR CAGR
79.07%
10 YEAR CAGR